Deep Intelligence Across Industries

Company Headquarters: Minnesota, US Founded: 2009 Workforce: ~100 Company Working: HistoSonics, Inc. is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. The company’s new platform deliverers personalized, tissue-specific treatments with precision and control , and without the undesirable side effects of many of today's interventional and surgical modalities, allowing physicians to continuously monitor the treatment and its effect in real-time. HistoSonics is run by a group of knowledgeable industry leaders. HistoSonics, Inc. was established to further the advancement of histotripsy, a ground-breaking scientific discovery and development made by eminent researchers at the University of Michigan to give patients with better therapy.

Company Headquarters: Founded: 1972 Workforce: ~600 Company Working: HealthTronics, Inc. offers integrated urological and interventional radiology products and services. The company offered exceptional, minimally invasive, mobile medical therapies for clinically sophisticated applications for more than 30 years. The company also provides repair and maintenance services in addition to lithotripsy, laser therapy, cryotherapy, and information technology solutions. Additionally, the organization provides healthcare practitioners across the United States with access to its cutting-edge technology and support systems. Furthermore, it provides its customers with a comprehensive platform of products and services and is the partner of choice for equipment manufacturers.

Company Headquarters: North Carolina, US Founded: 2004 Workforce: ~117 Company Working: Sonablate designs and manufactures HIFU surgical ablation systems that offer physicians and patients both clinical effectiveness and quality-of-life interventions. It also offers laparoscopic invasive hhigh-intensityfocused ultrasound (HIFU) surgical ablation system, fully integrated multi-transducer technology, and ultrasound-based imaging and assessment technology. The company is a leader in the development and advancement of minimally invasive HIFU technology. It is a global leader in HIFU therapies, with over 15,000 patient procedures completed and regulatory clearance in over 50 countries around the globe.

Company Headquarters: Quebec, Canada Founded: 2003 Workforce: ~ 1,500 Company Working: Pendopharm manufactures and distributes pharmaceutical products. The Company offers licensing, partnering, developing, and marketing specialty prescription medicines, as well as consumer healthcare products. Pendopharm serves customers in Canada. Moreover, it also offers more than 40 specialty products across multiple therapeutic areas. Pendopharm operates as a subsidiary of Pharmascience Inc. In addition, the company established lasting and fruitful relationships with Canadian healthcare professionals through the development of partnerships and sustained delivery of quality products and value-added service.

Company Headquarters: Connecticut, US Founded: 1983 Workforce: ~ 3,100 Company Working: Breckenridge Pharmaceutical, Inc. (Breckenridge) is a pharmaceutical marketing, research, and development company. The company's products include tablets, capsules, soft gel capsules, liquids, suspensions, ophthalmic powders, nasal sprays, and powders, enabling customers to enhance their health standards., Additionally, the company has over 80 products in development, 25 of which involve Paragraph IV patent challenges. Furthermore, it is operating as a subsidiary of Towa Pharmaceutical (Osaka, Japan), markets and distributes quality, cost-effective generic pharmaceuticals in the US.

Company Headquarters: Mumbai, India Founded: 1975 Workforce: ~ 200-500 Company Working: Sisco Research Laboratories Pvt. Ltd. (SRL), one of India's oldest and most reputable manufacturers and suppliers, manufactures and provides almost 5000 high-quality Laboratory Chemicals and Related Products. The business specialises in culture media, high purity solvents, BioLitTM DNA & Protein Tools for PCR and conventional molecular biology, as well as Molecular Biology Reagents, Biochemicals, Enzymes, Nanopowders, and Carbon Nanotubes. SRL was founded in 1975, and for more than 40 years the company has been producing highly sophisticated, high-quality biochemicals and reagents in India. Around 5000 goods in various grades, product sectors, and conventional packing sizes are produced and marketed by the company. The company also provides these high-tech chemicals in bulk and semi-bulk packs for the broader requirements of R&D and production units of various companies, universities, and research institutes.

Company Headquarters: Florida, US Founded: 2005 Workforce: ~100 Company Working: LGM Pharma is one of the active pharmaceutical ingredient companies that offers API sourcing as well as drug product contract development and manufacturing solutions to the biotechnology, pharmaceutical, and compounding pharmacy industries. It has ISO 9001:2015 certification. The company has an unparalleled network of prequalified cGMP API manufacturers around the globe. It has US-based manufacturing and warehouse facilities and has delivered more than 6,000 APIs to its clients in the last three years.

Company Headquarters: Barcelona, Spain Founded: 2007 Workforce: ~50 Company Working: Institute BCN is a well-established cosmeceutical company which is specialized in mesotherapy, cosmetics, derma pens, skin needling, skin needling serums, micro-needling, and transdermal delivery products. The company offers effective, safe, and scientifically tested cosmetic solutions in the mesotherapy market. The company has a strong distribution network in more than 60 countries.

Company Headquarters: Lausanne, Switzerland Founded: 1981 Workforce: 5,700 Company Working: Galderma Laboratories, L.P. (Galderma) develops products in the field of aesthetics, prescription medicines, and consumer care. Galderma Laboratories, L.P. offers a wide portfolio of products used to treat different dermatological conditions. The company is present in more than 100 countries, with six manufacturing units across the world. In October 2019, the business changed its name from Nestlé Skin Health to become the biggest independent dermatology company in the world. A group of prominent institutional investors, including the EQT VIII fund, Luxinva (an entirely owned subsidiary of the Abu Dhabi Investment Authority), PSP Investments, and others, purchased it. The company works with medical professionals from all around the world to address the demands of people's skin health throughout their lifetimes. The company has a strong presence in North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa.

Company Headquarters: Manresa, Spain Founded: 1997 Workforce: ~50 Company Working: Toskani Cosmetics is the fastest-growing cosmetic company. The company manufactures various cosmetics products such as serum cleansers, eye creams, scrubs, slimming gels, and hair care mesotherapy products for dermatological disorders. Toskani has vast years of experience in developing and manufacturing mesotherapy, cosmetic, and chemical peeling products. The company has a strong business presence in North America, Europe, Asia-Pacific, and the Rest of the World.

Company Headquarters: Spain, Europe Founded: 2004 Workforce: ~30 Company Working: Fusion Meso is a manufacturer of skincare products. Its primary area of expertise is sterile cosmetics, and it can be used with a variety of devices. The products are manufactured in their own facility in Spain. It provides a variety of non-invasive treatments and products that can be used in conjunction with aesthetic medicine procedures such as fillers, botox, laser, and mesotherapy. Each product is unique and aids in the restoration of healthy, glowing skin. Its products are sold in over 65 countries worldwide.

Company Headquarters: Seoul, South Korea Founded: 2016 Workforce: ~50 Company Working: Koru Pharmaceuticals Co., LTD. manufactures innovative cosmetological solutions for the needs of patients and aesthetic practitioners. It has become one of the major players in the medical aesthetics market with a global network of distributors and an extensive product portfolio available in more than 80 countries. Its manufacturing sites are present in South Korea, the US, and Europe.

Company Headquarters: Denmark, Europe Founded: 2013 Workforce: ~10 Company Working: Mesoskinline is a manufacturer of non-invasive products, equipment, and devices. Through testing, the company has discovered unique combinations and a balance of active ingredients delivering fast and optimum results for fine and deep lines in the skin, as well as for pigmentation, scars, lose or dehydrated skin, stretch marks, and hair loss. Mesoskinline is part of Mesotech (Italy), an Italian company which is manufacturing and distributing sterile medical devices, skincare solutions, and aesthetics for beauty and medical institutes.

Company Headquarters: France, Europe Founded: 1978 Workforce: ~500 Company Working: FILORGA designs and manufactures injectables used by specialists in aesthetic medicine. Its cosmetic products contain high molecular weight hyaluronic acid, encapsulated in chronospheres. Some other Filorga products contain micro-fragmented hyaluronic acid. These products are sold in more than 60 countries around the world. FILORGA’s largest markets are Italy, Spain, France, and Greater China. It provides face care, eye contour, and body care products. Colgate-Palmolive Co. (US) acquired Filorga for USD 1640.52 million in September 2019.

Company Headquarters: France Founded: 1994 Workforce: ~ 2500 Revenue: USD 0.53B (31-Dec-2021) Company Working: The LFB group is a biopharmaceutical company that develops, manufactures, and markets medicinal products for the treatment of serious and often rare diseases in the fields of Immunology, Haemostasis, Perinatal, and Intensive Care. The LFB group is the leading manufacturer of plasma-derived medicinal products in France and 6th worldwide and is also among the leading European companies for the development of new-generation medicinal products or treatments based on biotechnologies. The LFB group is pursuing a growth strategy that seeks to extend its international activities and develop innovative therapies.

Company Headquarters: Switzerland Founded: 1982 Workforce: ~113 Revenue: USD 2.84B Company Working: Octapharma AG (Octapharma) is a human protein product manufacturer that focuses on developing and producing medicines through human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy, hematology, and critical care therapeutic areas. It sources plasma from company-owned plasma donation centers and other external sources. Octapharma owns plasma donation centers in the US and Germany and owns production facilities in Austria, Germany, France, Mexico, and Sweden. The company’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labeling, packaging, storage, and distribution. Octapharma is headquartered in Lachen, Switzerland.

Company Headquarters: Herzliya, Israel Founded: 1994 Workforce: ~200 Company Working: Canndoc is a manufacturer of pharma-grade medical cannabis products for more than 13 years. In September 2018, Canndoc was acquired by InterCure (Israel), a medical device company focused on respiratory treatment; in the last 13 years, the company provided millions of doses to 40,000 patients. It has significant expertise in research, cultivation and processing, product development, and advanced GMP clinical trials pipeline initiation. Canndoc provides Good Manufacturing Practice (GMP) pharma-grade cannabis solutions to the patients for their health and treatment outcomes. Canndoc expanded its global production and distribution capabilities by making commercial agreements and joint ventures in Europe and Canada. Its proprietary genetic bank involves more than thirty unique cannabinoid profiles. The company has a presence in Canada, the UK, Portugal, Denmark, Germany, and Israel.

Company Headquarter: Nevada, US Founded: 2001 Workforce: ~50 Company Working: GB Sciences, Inc. is a phytomedicine research and biopharmaceutical drug development company that converts the cannabis plant into medicines, therapies, and treatment-based drugs. The company’s novel drug development pipeline is built through collaborations with top university researchers and industry leaders in novel delivery and manufacturing processes. It operates numerous subsidiaries such as Growblox Life Sciences LLC (US), Growblox Sciences Puerto Rico LLC (US), GB Sciences Las Vegas, LLC (US), and GB Sciences Nevada, LLC (US).

Company Headquarter: Connecticut, US Founded: 2004 Workforce: ~50 Company Working: Cara Therapeutics, Inc. is an emerging biotechnology company that develops novel therapeutics to treat pain, inflammation, and pruritus. It is a clinical-stage biotechnology company working on cannabinoid receptors to develop alternative treatment solutions for patients. The company’s advanced patented compound CR845 is undergoing various clinical tests for uremic pruritus and acute pain. Cara Therapeutics, Inc. has a group of medical experts, scientists, and industry leaders helping in providing innovative solutions to patients.

Company Headquarter: Ontario, Canada Founded: 2013 Workforce: ~1800 Company Working: Tilray Brands, Inc. (Tilray) engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company is focusing on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: cannabis and hemp. The cannabis segment sales consist of adult-use, medical, and bulk sales of cannabis under-regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to the patient. The hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD sold in an unlicensed operation and sold to retail, wholesale, and direct to consumers. It is a GMP-certified medical cannabis producer, which supplies cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments, and researchers on five continents. Its subsidiaries include Manitoba Harvest (Canada), High Park Company (Canada), Tilray Australia & New Zealand, Tilray Canada, Tilray Europe, and Tilray Latin Americas. In 2018, the company created a Medical Advisory Board, which guides its clinical trial selection process and product development initiatives. It has seven production and processing facilities, including one in Portugal, three cultivation sites in Ontario & British Columbia, and three processing facilities in Manitoba & Ontario. In May 2021, Tilray and Aphria Inc. (Canada) announced their merger in an all-stock deal. The company is directly present in more than 10 countries and has a strong presence in all the established markets such as North Americas, Europe, Africa, and Australia. It also focuses on the research and development of innovative products and spends a significant amount of revenue on R&D

Company Headquarter: Nevada, US Founded: 2005 Workforce: ~50 Company Working: Cannabis Sativa, Inc. has operations in three divisions: telemedicine, contrast manufacturing, and brand development & marketing of products and services in the CBD and marijuana industries. It operates through its subsidiaries, including Wild Earth Naturals (US), White Rabbit (India), hi Brands International (US), Presto Doctor (US), and iBudtender (Canada). It offers products and services to both businesses and consumers and is a publicly-traded company listed as OTCQB: CBDS. The company’s main operations run through its 51% owned telehealth subsidiary PrestoDoctor. PrestoDoctor is a proprietary online telemedicine platform that gives customers access to physicians to obtain a recommendation for medical marijuana.

Company Headquarters: UK, Europe Founded: 2013 Workforce: 500 Company Working: BenevolentAI is a clinical-stage AI-enabled drug discovery and development company. Through the combined capabilities of its AI platform, scientific expertise, and web-lab facilities, Benevolent AI is well-established to deliver novel drug candidates with a higher probability of clinical success. Moreover, BenevolentAI powers a growing in-house pipeline of 13 named drug programmers, and it maintains collaboration with AstraZeneca (UK), as well as research and charitable institutions. The company offers its services under the category of pipeline, COVID-19, atopic dermatitis, and ulcerative colitis as well as company has a strong market presence in Europe.

Company Headquarters: Toronto, Canada Founded: 2013 Workforce: 200 Company Working: Cyclica is a data-driven drug discovery company. The company’s calculation method for polypharmacology is unique in the industry. Cyclica used a proteome-wide lens to measure novel and off-target interaction instantaneously. The company offers its product and services under the category of drug development, network pharmacology, drug repositioning, proteomics, clinical trials, side effects, bioinformatics, systems biology, drug discovery, artificial intelligence, polypharmacology, medicines, machine learning, pharmacology, pharmaceuticals, and bioinformatics. The company has a strong business presence in Canada.

Company Headquarters: Hong Kong, China Founded: 2014 Workforce: 200 Company Working: Insilico Medicine is a technology company specializing in drug discovery and drug development processes. It offers products under the category of pharma.AI suite, pandaomics, chemistry42, and inclinico. The company is dedicated to expanding human productive longevity and transforming every step of the drug discovery and drug development process by best practices in biomarker discovery, drug development, digital medicine, and aging research. The company has a strong business presence in the US, China, Canada, UAE, Belgium, the UK, and Taiwan.

Company Headquarters: North Carolina, US Founded: 2009 Workforce: ~500 Company Working: Cloud Pharmaceuticals is a leader in the emerging field of artificial intelligence-based drug development. It is currently researching new medications at the clinical stage. The company works with the pharmaceutical, biotechnology, and medical research industries to develop, generate, and provide licenses for cutting-edge medicinal molecules for a range of medical purposes. Additionally, it produces innovative medications through vertical holdings, frequently LLCs for certain therapeutic areas.

Company Headquarters: Ontario, Canada Founded: 2015 Workforce: ~200 Company Working: Deep Genomics is a biotechnology company that builds proprietary Artificial Intelligence (AI) and uses it to discover new ways to correct the effects of genetic mutations and develop personalized therapies for individuals with rare Mendelian and complex diseases. It offers cell and molecular biology, clinical development, molecular genetics, organic chemistry, preclinical development, and other solutions. The company's AI platform generates billions of data points using throughput assays and sophisticated robotics systems and creates dozens of engineered and validated machine learning systems to support drug development. This allows researchers to categorize, rank, interpret, and link genetic variants, whether they are therapeutic or natural. Furthermore, Deep Genomics serves customers in Canada.

Company Headquarters: California, US Founded: 2012 Workforce: ~ 63 Company Working: Atomwise Inc. (Atomwise) a creative pharmaceutical company, is revolutionizing the search for small-molecule drugs by utilizing AI. The platform for AI-based, structure-based drug development is offered by Atomwise. Deep learning neural networks are used by Atomwise to find new medications. The company achieved the highest outcomes in the world for toxicity detection, binding affinity prediction, and the development of novel pharmacological hits. With three lead-optimization efforts and more than 30 discovery programs, Atomwise is building a wholly owned pipeline of small-molecule pharmaceutical prospects. Additionally, the Bill and Melinda Gates Foundation (US) awarded the company a 2.3 USD million grant in 2020 to support the creation of numerous global health initiatives that will advance cutting-edge antimalarial and anti-tuberculosis small molecule therapies in conjunction with the foundation's extensive network. In addition, Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID-19. The company operates in California US.